• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.17%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    181.96 Up 3.09(1.73%) Dec 24, 1:00PM EST
    Add to Portfolio
    Prev Close:178.87
    Open:179.35
    Bid:N/A
    Ask:196.00 x 100
    1y Target Est:209.90
    Beta:1.4
    Earnings Date:Jan 28 - Feb 2 (Est.)
    Day's Range:179.34 - 185.78
    52wk Range:126.76 - 203.30
    Volume:433,756
    Avg Vol (3m):1,180,570
    Market Cap:36.08B
    P/E (ttm):75.69
    EPS (ttm):2.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALXN

    Comparison

    Symbol% ChgMkt Cap
    ALXNUp 1.73%36.08B
    AMGNUp 2.00%122.22B
    BAXDown 0.05%40.35B

    Key Statistics

    Forward P/E (1 yr):30.74
    P/S (ttm):17.08
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :5.20
    Quarterly EPS Est (Dec-14) :1.29
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.14

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback